Loading viewer...
presentation
Format: PDF presentation
Cellectis Biologics presents its commitment to developing allogeneic CAR T-cells, highlighting its innovations and clinical trials in gene editing.
presentation
presentation
OMV Aktiengesellschaft
presentation
California Resources Corporation
presentation
Ely Gold Royalties
presentation
8x8 Inc